Since IL6 is an activator of multiple signaling pathways, which can affect the expression level of key proteins of signaling pathways, and the Rever Phase Protein Array (RPPA) in LinkedOmics [21] provides relevant protein data of prostate cancer tissues, we select it to explore the role of IL6 in prostate cancer. This evidence concerns the gene IL6 and Familial prostate cancer.